Maryvonne Hiance Chairman of France Biotech

Latest Posts

OSE Immunotherapeutics announces voluntary pause of enrollment in the CoVepiT Phase 1 study

20 July 2021

OSE Immunotherapeutics today announced a voluntary and temporary pause of enrollment and dosing in its ongoing Phase 1 clinical trial... View Article

OSE Immunotherapeutics Receives a €10 Million Payment Corresponding to the First Tranche of the Financing Granted by the European Investment Bank

19 July 2021

This financing will further support the progress and expansion of OSE Immunotherapeutics’ lead clinical development programs in therapeutic areas with... View Article

Interview with Olivier Boisteau – Vice-President of Clean Biologics and of Atlanpole Biotherapies.

13 July 2021

Leader of a group of over 200 people at Clean Biologics, a company offering a range of high-tech services to... View Article

« Previous 1 … 48 49 50 51 52 … 160 Next »